Substance for inhibiting tissue calcification, tissue fibrosis and age-associated diseases
DE102011082871A1
Use of an active agent that inhibits or activates a gene e.g. ubiquitin specific peptidase 18 for preventing and treating autoimmune, inflammatory and immune disorders e.g. acute hepatitis, malaria, HIV infection, rabies or osteoarthritis
DE102009015917A1
Use of an active agent comprising resveratrol, thymol, xanthohumol or vitamin C for inhibition and/or prophylaxis of e.g. eryptosis, acute renal failure, anemia, shock, atherosclerosis, thrombosis, diabetes mellitus and sickle cell anemia
DE102008029072A1
Substance, which inhibits serum and glucocorticoid dependent kinase 3, useful for the prophylaxis and/or treatment or diagnosis of age-related diseases e.g. arteriosclerosis, skin atrophy, myasthenia, infertility, stroke and kyphosis
DE102008010362A1
Sgk1 as a therapeutic and diagnostic target for viral diseases
DE102008010363A1
Sgk1 as a therapeutic and diagnostic target for carcinomatous diseases
WO2007025792A1
Method for diagnosing hypertonia
RU2331072C2
sgk1 AS DIAGNOSTIC AND THERAPEUTIC TARGET
PL377234A1
Sgk1 as diagnostic and therapeutic target
CA2517958A1
Sgk1 as diagnostic and therapeutic target
DE10305212A1
Use of the sgk gene family for the diagnosis and therapy of cataracts and glaucoma
DE10305213A1
Use of a new polymorphism in the hsgk1 gene to diagnose hypertension and use of the sgk gene family to diagnose and treat Long-Q / T syndrome
DE10225844A1
sgk and nedd as diagnostic and therapeutic targets
DE10219545A1
Regulation of apoptosis
HU0303491A2
Quantitative diagnostic analysis of hypertonia
DE10210206A1
Method for reduction of fertility in vertebrates, including human males, comprises treatment of eukaryotic cells with an agent that alters the pH of epididymal luminal fluid
DE10149393A1
Detecting the expression of serum and glucocorticoid-dependent kinase-1 (sgk1), for diagnosing coagulative diseases, diabetes, tumors, diabetes and autoimmune diseases, comprises using an antibody against sgk1
DE10104825A1
Antimalarial screening
DE10042853A1
Detection and influencing of the expression or function of CD95 / CD95L in infections
DE10042137A1
sgk2 and sgk3 as diagnostic and therapeutic targets
